Avita Medical Ltd (OTCQX:AVMXY) has developed an autologous cell harvesting, processing and delivery technology that enables surgeons and clinicians to treat complicated skin defects, including chronic wounds, scars, burns, depigmentation, and aid in rejuvenation or reconstruction procedures. ReCell® Spray-On Skin uses a patient's own skin cells to facilitate a regenerative process during which new skin is regrown. A small biopsy of the patient's skin is removed (about the size of a postage stamp), and the cells are disaggregated using the ReCell kit as described in greater detail in this patient brochure and the picture below.
The resulting cell suspension, which is sprayed onto an affected area to be treated, contains the appropriate mixture of healthy cells of...
Only subscribers can access this article, which is part of the PRO research library covering 3,575 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: